This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Autism spe
KRA_PSY_AUTISM
autism: A disorder characterized by marked impairments in social interaction and communication accompanied by a pattern of repetitive, stereotyped behaviors and activities. Developmental delays in social interaction and language surface prior to age 3 years.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1241 |
4. Check minimum number of eventsNone |
1241 |
5. Include endpointsNone |
1241 |
6. Filter based on genotype QC (FinnGen only) |
1101 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Autism spe
based on the number of shared cases.
Similar with more cases:
- Autism spe, excluding more controls
- Autism
- Wide developmental disorders, excluding more controls
- Wide developmental disorders
- Disorders of psychological development
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1101 | 573 | 528 |
| Unadjusted period prevalence (%) | 0.22 | 0.20 | 0.24 |
| Median age at first event (years) | 25.66 | 28.17 | 22.95 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1166
- Matched controls
- 11660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F90.0
ICD-10 Finland
Disturbance of activity and attention
9.7
307.7
530
919
F84.5
ICD-10 Finland
Asperger syndrome
5994.8
307.7
1082
25
N06BA04
ATC
methylphenidate; oral
9.1
284.9
465
795
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
47.3
233.2
138
33
N05AX08
ATC
risperidone; systemic
9.2
219.3
313
447
N05AH04
ATC
quetiapine; oral
5.9
202.0
582
1673
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.2
162.0
484
1393
N06AX12
ATC
bupropion; oral
5.9
155.1
355
809
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
7.8
149.8
234
363
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
6.7
149.3
278
519
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
9.3
148.2
194
244
N05AX12
ATC
aripiprazole; systemic
6.7
144.5
270
505
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.7
144.3
265
487
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.6
135.6
466
1469
F84.0
ICD-10 Finland
Childhood autism
1410.0
131.9
126
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.7
128.5
284
619
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
6.7
126.2
226
402
ZY010
NOMESCO Finland
Hospital outpatient
5.5
116.0
268
604
N06AX16
ATC
venlafaxine; oral
4.6
114.9
359
1036
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.4
113.8
214
398
F84.8
ICD-10 Finland
Other pervasive developmental disorders
30.8
113.3
75
26
N05AH03
ATC
olanzapine; systemic
5.4
112.8
261
588
N06AB03
ATC
fluoxetine; oral
5.0
109.5
289
727
N06BA12
ATC
lisdexamfetamine; oral
8.2
109.2
155
213
N06AB06
ATC
sertraline; oral
4.2
104.8
365
1134
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
6.8
103.5
177
298
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.3
100.9
333
992
N03AX09
ATC
lamotrigine; oral
5.6
97.3
207
430
ZYC01
NOMESCO Finland
Remote contact by phone
5.4
92.7
205
440
P29
ICPC
Psychological sympt/compl other
3.8
87.5
344
1148
Z2445
NOMESCO Finland
Psychologist
4.8
84.4
218
532
N06AB10
ATC
escitalopram; oral
3.3
83.9
489
2087
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.4
82.8
427
1690
F34.1
ICD-10 Finland
Dysthymia
6.4
81.0
145
254
N05BA04
ATC
oxazepam; oral
3.4
78.6
400
1563
P99
ICPC
Psychological disorders other
5.9
75.9
146
274
N06AX26
ATC
vortioxetine; oral
3.9
75.7
265
809
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.6
75.3
203
510
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
6.7
74.0
125
206
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
9.5
72.2
88
99
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.6
71.4
193
485
IGV01
NOMESCO Finland
Psychiatric network contact
7.4
71.0
108
159
Z2446
NOMESCO Finland
Social worker
4.1
68.3
220
630
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.5
66.8
185
473
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.9
66.6
225
666
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.4
65.6
114
193
N06AX11
ATC
mirtazapine; oral
2.9
64.8
474
2235
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.5
64.2
172
428
SPAT1240
SPAT
Therapeutic discussion
3.2
63.3
329
1280
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.9
61.3
147
334
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
15.5
59.1
52
35
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.3
58.5
167
435
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
6.0
57.9
107
192
N06AB04
ATC
citalopram; systemic
3.4
57.6
249
862
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.7
57.1
143
336
F61.0
ICD-10 Finland
Mixed personality disorders
7.8
55.7
79
107
N03AG01
ATC
valproic acid; systemic, rectal
4.5
55.2
146
358
SPAT1307
SPAT
Psychosocial counselling and guidance
3.1
54.5
280
1073
F93.89
ICD-10 Finland
Other childhood emotional disorders
5.9
54.1
101
183
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.4
53.0
223
757
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.3
52.3
146
373
F40.1
ICD-10 Finland
Social phobias
4.1
52.2
157
424
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
5.2
52.0
114
239
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.5
51.4
136
333
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
11.5
50.5
53
48
N05AB03
ATC
perphenazine; systemic, rectal
6.4
49.8
86
144
N06AX21
ATC
duloxetine; oral
3.5
49.6
195
632
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.8
49.0
93
171
F83
ICD-10 Finland
Mixed specific developmental disorders
6.2
48.4
86
148
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
7.3
45.7
69
100
P03
ICPC
Feeling depressed
2.6
45.1
343
1600
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.0
44.6
82
146
N06BA09
ATC
atomoxetine; oral
8.2
43.8
59
75
P01
ICPC
Feeling anxious/nervous/tense
2.4
43.1
457
2476
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.6
42.5
84
160
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.3
42.3
73
122
IBZ08
NOMESCO Finland
Gender identity assessment
12.0
42.3
43
37
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.9
42.2
133
370
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.0
41.6
127
345
P76
ICPC
Depressive disorder
3.0
40.4
208
788
OAB43, ,
SPAT
0.4
39.7
235
4671
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.2
38.2
82
168
F89
ICD-10 Finland
Unspecified disorder of psychological development
13.2
37.6
36
28
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.4
37.3
148
479
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.0
36.8
57
85
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
8.4
36.5
48
59
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
6.1
36.5
65
112
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
36.4
314
1533
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.0
36.4
108
287
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.7
35.3
86
196
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.1
35.1
102
267
F60.5
ICD-10 Finland
Anankastic personality disorder
7.8
35.0
49
65
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
34.4
127
392
N05AE04
ATC
ziprasidone; systemic
9.8
34.3
40
42
P81
ICPC
Hyperkinetic disorder
4.7
34.1
83
189
N06AX22
ATC
agomelatine; oral
4.7
34.1
81
181
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.8
34.0
112
320
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.5
33.7
67
128
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
8.4
33.5
44
54
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.7
33.4
114
334
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
7.2
33.3
50
72
F21
ICD-10 Finland
Schizotypal disorder
11.6
32.8
34
30
F33.8
ICD-10 Finland
Other recurrent depressive disorders
7.7
32.4
46
62
SPAT1389
SPAT
Visit based on need for special support
3.0
32.4
157
571
F64.0
ICD-10 Finland
Transsexualism
10.9
32.3
35
33
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.0
32.2
95
251
N05AD01
ATC
haloperidol; systemic
7.0
31.2
48
71
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.2
30.9
85
213
ZYY01
NOMESCO Finland
Contact between professionals
8.0
30.8
42
54
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
6.9
30.8
48
72
R4110, ,
SPAT
3.2
30.5
134
460
SPAT1243
SPAT
Psychiatric/psychological examination
3.5
30.4
113
350
N06AB05
ATC
paroxetine; oral
3.9
30.3
92
248
N05AN01
ATC
lithium; oral
4.9
30.2
69
149
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
8.1
29.5
40
51
C07AA05
ATC
propranolol; systemic
2.2
29.5
308
1615
N05AF03
ATC
chlorprothixene; systemic
5.5
29.2
57
107
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
29.0
77
188
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
5.0
28.8
64
135
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.1
28.6
61
124
N06BA02
ATC
dexamfetamine; oral
11.4
28.5
30
27
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
8.8
28.5
36
42
N05BA01
ATC
diazepam; systemic, rectal
2.9
28.5
144
535
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
9.4
28.4
34
37
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
28.2
112
361
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.6
28.2
100
300
P74
ICPC
Anxiety disorder/anxiety state
2.7
27.7
165
668
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.2
27.7
120
408
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.1
27.7
80
208
ICB06, ,
NOMESCO Finland
5.3
27.6
56
109
F50.8
ICD-10 Finland
Other eating disorders
9.4
27.5
33
36
ZY000
NOMESCO Finland
Hospital inpatient
5.2
27.5
58
117
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
8.1
27.4
37
47
Z3231
NOMESCO Finland
Registered nurse
2.1
26.9
353
2012
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
8.0
26.5
36
46
SPAT1284
SPAT
Extensive health certificate
3.9
26.0
79
213
N06AG02
ATC
moclobemide; oral
5.2
25.8
54
108
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
25.8
257
1314
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
25.2
269
1412
F88
ICD-10 Finland
Other disorders of psychological development
9.9
25.1
29
30
N05BE01
ATC
buspirone; oral
4.6
25.0
60
135
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.8
24.9
140
549
F31
ICD-10 Finland
Bipolar affective disorder
5.8
24.4
45
80
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.7
24.3
57
126
SPAT1234
SPAT
Support of social functional capacity
4.2
24.2
66
164
IEV99
NOMESCO Finland
Other psychiatric network intervention
5.1
24.1
51
103
Z07
ICPC
Education problem
4.3
24.1
64
156
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
5.2
23.9
50
100
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.9
23.8
73
198
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.3
23.7
40
65
IGY02, ,
SPAT
4.4
23.7
61
145
M35.7
ICD-10 Finland
Hypermobility syndrome
5.1
23.6
50
101
F32.1
ICD-10 Finland
Moderate depressive episode
2.5
23.5
164
715
N05AX16
ATC
brexpiprazole; oral
9.0
23.4
29
33
ZYC02
NOMESCO Finland
Remote contact by video link
9.8
23.3
27
28
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.4
23.1
184
852
SPAT1310
SPAT
Counselling related to known health issue
1.9
23.1
445
2867
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
9.2
23.0
28
31
M79.7
ICD-10 Finland
Fibromyalgia
4.4
23.0
59
140
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.2
22.7
94
310
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
7.9
22.6
31
40
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
7.4
22.6
33
46
IER01
NOMESCO Finland
Psychoeducation, group
5.2
22.5
47
94
IHZ04, ,
SPAT
4.0
22.2
64
166
G47.3
ICD-10 Finland
Sleep apnoea
2.3
21.9
194
939
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.3
21.9
57
137
Z72.8
ICD-10 Finland
Other problems related to lifestyle
7.3
21.7
32
45
IAB03
NOMESCO Finland
Neuropsychiatric consultation
31.8
21.5
28
9
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
5.3
21.4
43
83
IGP01
NOMESCO Finland
Psychiatric family contact
3.9
21.2
65
176
F33
ICD-10 Finland
Recurrent depressive disorder
3.5
21.1
74
220
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.2
21.1
88
292
N06AX03
ATC
mianserin; oral
4.5
21.0
52
120
N03AE01
ATC
clonazepam; systemic
3.8
20.7
65
179
N04AA02
ATC
biperiden; systemic
6.3
20.7
35
57
IHZ05, ,
SPAT
2.3
20.5
165
766
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
20.5
116
456
OAA68, ,
SPAT
4.8
20.5
46
98
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
20.4
92
319
N05AA02
ATC
levomepromazine; systemic
3.9
20.4
62
167
N02BF02
ATC
pregabalin; oral
3.2
20.3
84
277
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.6
20.3
69
201
R1250, ,
SPAT
3.3
20.1
78
247
N05BA06
ATC
lorazepam; systemic, sublingual
4.1
20.0
56
142
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
7.7
20.0
28
37
P85
ICPC
Mental retardation
7.7
20.0
28
37
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
20.0
92
323
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.4
19.8
50
117
W78
ICPC
Pregnancy
0.4
19.8
94
2225
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
6.1
19.6
34
57
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.5
19.6
68
201
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
4.9
19.5
43
90
P06
ICPC
Sleep disturbance
2.1
19.5
215
1133
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.7
19.4
62
173
N05BA12
ATC
alprazolam; oral
2.9
19.4
97
357
N06AA04
ATC
clomipramine; systemic
6.4
19.3
32
51
F32
ICD-10 Finland
Depressive episode
2.6
19.3
121
500
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
6.6
19.3
31
48
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
17.1
19.2
30
18
SPAT1229
SPAT
Assessment of need for aid
4.5
19.1
47
108
SPAT1139
SPAT
Nutrition survey
4.5
19.1
47
108
IEY01
NOMESCO Finland
Psychoeducation, individual
5.0
19.1
41
84
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
5.3
19.0
38
73
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
5.3
19.0
38
73
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
5.2
18.9
39
77
T05
ICPC
Feeding problem of adult
5.1
18.9
40
81
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.4
18.6
69
213
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
4.4
18.4
47
111
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
18.4
224
1222
AA400
NOMESCO Finland
Electroconvulsive therapy
7.0
18.3
28
41
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
18.3
104
409
T82
ICPC
Obesity
3.1
18.2
79
268
F60.8
ICD-10 Finland
Other specific personality disorders
7.1
17.9
27
39
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
6.1
17.8
31
52
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
5.8
17.6
32
56
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.8
17.6
93
352
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.6
17.5
59
171
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.0
17.5
50
129
ZXY49
NOMESCO Finland
Other health care provider
6.5
17.2
28
44
F32.8
ICD-10 Finland
Other depressive episodes
3.8
17.1
52
140
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.5
16.9
110
463
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
16.8
141
664
N05CF01
ATC
zopiclone; oral
2.0
16.7
213
1179
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.7
16.7
39
86
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.2
16.6
44
107
N05AE05
ATC
lurasidone; oral
7.1
16.6
25
36
F84.10
ICD-10 Finland
Autism in atypical age
172.4
16.5
17
*
R5599
NOMESCO Finland
Other rehabilitation service
3.8
16.5
51
139
N05AX15
ATC
cariprazine; oral
6.2
16.4
28
46
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
16.4
151
2780
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.3
16.3
51
1493
P27
ICPC
Fear of mental disorder
3.8
16.3
50
136
SPAT1301
SPAT
No procedures
1.8
16.2
362
2385
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
5.2
16.1
33
65
N03AX11
ATC
topiramate; oral
3.6
15.9
54
157
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
15.8
123
2414
N05CF02
ATC
zolpidem; oral
2.2
15.8
151
749
F50.0
ICD-10 Finland
Anorexia nervosa
4.6
15.7
37
82
N06AX05
ATC
trazodone; oral
4.2
15.7
42
103
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
15.7
124
569
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
15.7
201
1113
OAA80, ,
SPAT
0.3
15.6
40
1306
Z02.7
ICD-10 Finland
Issue of medical certificate
2.4
15.6
115
512
P86
ICPC
Anorexia nervosa/bulimia
6.3
15.5
26
42
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
6.3
15.5
26
42
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.9
15.5
34
71
R5140
NOMESCO Finland
Monitoring the use of the aid
2.7
15.5
87
340
N03AX16
ATC
[U] pregabalin
2.1
15.3
155
786
Z29
ICPC
Social problem NOS
3.4
15.3
55
166
A01
ICPC
Pain general/multiple sites
2.4
15.1
114
512
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.9
15.0
45
120
IEP99
NOMESCO Finland
Other psychiatric family intervention
4.5
15.0
37
85
P79
ICPC
Phobia/compulsive disorder
4.7
15.0
35
77
IBA01, ,
SPAT
2.9
15.0
70
248
SPAT1051
SPAT
Guidance regarding sleep disorders
4.3
14.9
38
90
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
32.2
14.8
19
6
WZC00, ,
SPAT
1.8
14.8
241
1441
Z06
ICPC
Unemployment problem
4.8
14.8
33
70
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
4.0
14.6
42
109
IGY99, ,
SPAT
2.4
14.5
101
438
F80.2
ICD-10 Finland
Receptive language disorder
4.2
14.5
38
92
N06AX17
ATC
milnacipran; oral
15.6
14.4
23
15
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
12.7
14.4
25
20
N05AH02
ATC
clozapine; systemic
3.5
14.4
49
143
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
4.9
14.3
31
64
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
14.3
94
397
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
5.4
14.2
28
53
IAA01, ,
SPAT
4.0
14.2
40
102
N06AB08
ATC
fluvoxamine; oral
5.8
14.2
26
46
IEP03
NOMESCO Finland
Focused parental counselling
5.2
14.2
29
57
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
6.1
13.9
24
40
WZA10, ,
SPAT
2.6
13.7
79
313
SPAT1260
SPAT
Consultation of another employee
1.9
13.5
196
1128
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
13.4
107
492
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
13.4
171
942
A28
ICPC
Limited function/disability NOS
2.7
13.4
73
281
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
4.1
13.3
36
89
F50.1
ICD-10 Finland
Atypical anorexia nervosa
5.0
13.1
28
57
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
4.5
13.1
32
73
Z08
ICPC
Social welfare problem
4.6
13.1
31
69
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
6.0
13.1
23
39
N06AX18
ATC
reboxetine; oral
11.1
13.0
24
22
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.4
13.0
46
138
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.6
12.9
74
292
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
12.9
76
1678
K03.66
ICD-10 Finland
Tooth plaque
2.0
12.8
146
773
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.2
12.8
110
523
SPAT1312
SPAT
General health counselling
1.6
12.7
475
3525
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
6.0
12.6
22
37
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.6
12.5
72
285
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
12.5
329
2241
ZXY60
NOMESCO Finland
2-person team, nurses
5.1
12.5
26
52
IHZ07, ,
SPAT
5.7
12.4
23
41
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
4.2
12.3
32
77
IAZ99
NOMESCO Finland
Other psychiatric consultation
5.9
12.3
22
38
Z3226
NOMESCO Finland
Physiotherapist
1.9
12.2
185
1077
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
12.2
85
369
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.4
12.2
64
1483
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
3.6
11.9
39
111
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.1
11.9
32
79
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
11.9
129
671
R1250
NOMESCO Finland
Evaluation of functional capability
3.8
11.8
35
93
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
5.2
11.8
24
47
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.4
11.8
84
1725
Z00.0
ICD-10 Finland
General medical examination
1.7
11.8
260
1688
F50.2
ICD-10 Finland
Bulimia nervosa
4.8
11.7
26
55
OAA11, ,
SPAT
0.3
11.7
31
1000
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
5.6
11.7
22
40
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
11.6
120
2167
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.1
11.6
109
537
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
11.5
123
635
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.6
11.5
37
104
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
5.1
11.5
24
48
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.3
11.3
25
893
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
5.6
11.2
21
38
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
12.9
11.2
19
15
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
11.1
61
236
R4120, ,
SPAT
5.8
11.0
20
35
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.9
11.0
24
50
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
11.0
557
4380
SPAT1395
SPAT
Health check-up of persons outside student and working life
3.7
11.0
35
98
OAA12, ,
SPAT
0.2
11.0
14
705
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.4
10.9
75
324
MA3AE
NOMESCO Finland
Combined first trimester screening
0.3
10.8
24
857
A04
ICPC
Weakness/tiredness general
1.7
10.8
241
1564
OAB48, ,
SPAT
0.5
10.8
112
2026
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.5
10.8
92
1777
SPAT1379
SPAT
Health check-up of pregnant person
0.4
10.8
69
1482
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
10.8
605
7230
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.9
10.8
50
177
ZYC01, ,
SPAT
1.7
10.7
221
1405
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.2
10.7
28
68
F84.11
ICD-10 Finland
Autism with atypical symptoms
60.6
10.6
12
*
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
5.3
10.6
21
40
SPAT1058
SPAT
PEF monitoring instruction
2.3
10.6
81
366
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.8
10.6
172
1021
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
8.6
10.6
22
26
R32
ICD-10 Finland
Unspecified urinary incontinence
4.7
10.5
24
52
N03AX12
ATC
[U] gabapentin; oral
2.1
10.4
107
544
R53
ICD-10 Finland
Malaise and fatigue
1.6
10.4
293
2015
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
7.8
10.4
23
30
F60.1
ICD-10 Finland
Schizoid personality disorder
16.2
10.4
16
10
OAB38, ,
SPAT
2.1
10.3
108
553
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
32.8
10.3
13
*
P98
ICPC
Psychosis NOS/other
4.5
10.3
25
57
C07AB07
ATC
bisoprolol; oral
1.7
10.3
202
1267
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.1
10.2
106
541
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
7.5
10.2
23
31
P72
ICPC
Schizophrenia
3.3
10.2
37
113
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.9
10.2
47
166
N06AA12
ATC
doxepin; systemic
3.7
10.1
32
89
183
Kela drug reimbursment
Lamotrigin and topiramate
4.3
10.1
26
62
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
4.4
10.1
25
58
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.2
10.1
39
124
N05CD07
ATC
temazepam; oral
3.3
10.1
38
119
L28
ICPC
Limited function/disability (L)
2.1
10.0
102
518
OAA43, ,
SPAT
2.4
9.9
69
300
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
9.8
827
9220
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
9.8
146
843
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.4
9.7
43
1078
SPAT1216
SPAT
Assessment of functional ability
2.1
9.6
91
449
N05AE03
ATC
sertindole; oral
11.5
9.6
17
15
SPAT1053
SPAT
Memory test
4.8
9.6
21
44
F22.0
ICD-10 Finland
Delusional disorder
7.2
9.5
22
31
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
3.3
9.5
36
113
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.2
9.5
84
404
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
9.3
59
245
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.3
204
1314
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
4.1
9.3
25
62
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.9
9.3
27
71
F61
ICD-10 Finland
Mixed and other personality disorders
13.8
9.2
15
11
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
13.8
9.2
15
11
SPAT1377
SPAT
Polysomnography
3.3
9.1
33
101
WZA00, ,
SPAT
2.3
9.0
70
319
P28
ICPC
Limited function/disability (P)
4.2
8.9
23
55
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
8.9
116
1967
A02BC02
ATC
pantoprazole; systemic
1.5
8.9
507
4026
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
12.6
8.9
15
12
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
12.6
8.9
15
12
OAB95, ,
SPAT
0.4
8.9
42
1025
IEP01
NOMESCO Finland
Psychoeducation, family
4.9
8.9
19
39
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
4.7
8.8
20
43
IHZ02, ,
SPAT
2.2
8.8
71
329
K59.0
ICD-10 Finland
Constipation
2.4
8.8
62
271
GD1AA, ,
SPAT
0.5
8.8
69
1379
OAA62, ,
SPAT
0.5
8.8
71
1404
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.7
8.8
27
74
R62.0
ICD-10 Finland
Delayed milestone
3.0
8.7
38
130
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.8
8.6
26
70
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
8.6
74
352
F95.9
ICD-10 Finland
Tic disorder, unspecified
9.1
8.5
17
19
Z10.0
ICD-10 Finland
Occupational health examination
0.4
8.5
50
1117
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.7
8.5
46
177
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.5
8.5
73
1415
OAA67, ,
SPAT
0.5
8.5
101
1763
OAB72, ,
SPAT
3.1
8.5
35
116
RT420, ,
NOMESCO Finland
7.4
8.5
19
26
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
4.3
8.4
21
49
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.4
8.4
29
86
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
8.4
104
566
G50.1
ICD-10 Finland
Atypical facial pain
4.5
8.4
20
45
IAA02, ,
SPAT
4.9
8.4
18
37
P23
ICPC
Adolescent behaviour sympt/compl
3.1
8.4
35
117
R4120
NOMESCO Finland
Occupational therapy
2.2
8.3
71
337
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
9.5
8.3
16
17
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.4
8.3
36
913
S22
ICPC
Nail symptom/complaint
2.1
8.3
82
412
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
4.1
8.3
22
54
ICB01, ,
SPAT
3.6
8.3
27
77
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.9
8.3
24
63
SPAT1097
SPAT
Recording of ECG
2.2
8.3
73
351
R96
ICPC
Asthma
2.0
8.2
92
483
ZXY03
NOMESCO Finland
Occupational therapist
6.5
8.2
20
31
C09CA06
ATC
candesartan; oral
1.7
8.2
147
896
OAA10, ,
SPAT
0.3
8.1
25
749
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
8.1
55
236
SPAT1380
SPAT
Postpartum check-up
0.5
8.1
58
1198
ICB07, ,
NOMESCO Finland
9.0
8.0
16
18
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
8.0
381
2906
OAA70, ,
SPAT
0.1
8.0
5
326
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.6
8.0
45
177
ZYC02, ,
SPAT
1.8
7.9
135
811
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
7.9
235
1626
R04
ICPC
Breathing problem other
2.6
7.9
44
172
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
13.1
7.9
13
10
R42
ICD-10 Finland
Dizziness and giddiness
1.7
7.8
158
994
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
1.8
7.8
112
639
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.7
193
1282
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
6.4
7.7
19
30
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
7.7
63
294
N03AF02
ATC
oxcarbazepine; oral
2.5
7.7
49
205
F41.00
ICD-10 Finland
Moderate panic disorder
2.7
7.6
39
146
F80.0
ICD-10 Finland
Specific speech articulation disorder
4.0
7.6
21
53
P20
ICPC
Memory disturbance
4.0
7.6
21
53
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.3
7.6
54
237
T08
ICPC
Weight loss
2.9
7.6
35
124
Z72.9
ICD-10 Finland
Problem related to lifestyle, unspecified
25.2
7.6
10
*
U04
ICPC
Incontinence urine
3.2
7.6
29
92
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.5
7.6
25
72
RS140, ,
NOMESCO Finland
6.2
7.6
19
31
3007
Kela drug reimbursment
Erenumab and fremanezumab
3.3
7.6
28
87
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.4
7.6
51
219
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
7.5
435
3432
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
4.3
7.5
19
45
H52.1
ICD-10 Finland
Myopia
2.0
7.5
77
393
IHZ01, ,
SPAT
2.8
7.4
36
131
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
7.4
32
109
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
6.0
7.4
19
32
N02BF01
ATC
gabapentin; oral
2.0
7.4
76
388
IHZ05
NOMESCO Finland
Therapeutic conversation
4.1
7.4
20
50
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
7.3
966
8825
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
9.4
7.3
14
15
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.9
7.3
33
116
XA820, ,
NOMESCO Finland
6.3
7.3
18
29
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
4.5
7.2
17
38
N05BA09
ATC
clobazam; oral
3.6
7.2
23
65
WVA30, ,
SPAT
2.3
7.1
52
231
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.3
7.1
26
80
F45.0
ICD-10 Finland
Somatization disorder
8.0
7.1
15
19
IEY19, ,
SPAT
6.1
7.1
18
30
IAB01, ,
SPAT
5.7
7.1
19
34
F81.0
ICD-10 Finland
Specific reading disorder
3.1
7.1
29
96
A03FA02
ATC
cisapride; oral, rectal
2.4
7.1
48
207
F80.1
ICD-10 Finland
Expressive language disorder
2.7
7.0
37
141
T07
ICPC
Weight gain
2.7
7.0
37
141
ZXY61
NOMESCO Finland
2-person team, special workers
7.0
7.0
16
23
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
3.4
7.0
24
71
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
7.0
48
208
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
6.9
122
739
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
6.9
452
3631
Z03
ICPC
Housing/neighbourhood problem
7.6
6.9
15
20
F64.8
ICD-10 Finland
Other gender identity disorders
13.9
6.9
11
8
H13
ICPC
Plugged feeling ear
1.7
6.9
143
907
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
8.3
6.8
14
17
P73
ICPC
Affective psychosis
8.3
6.8
14
17
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
6.8
82
442
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.8
132
821
XG466
NOMESCO Finland
Sleep oxymetry
3.8
6.8
20
53
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.8
6.8
20
53
F94.0
ICD-10 Finland
Elective mutism
11.0
6.8
12
11
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
9.4
6.8
13
14
N02CD01
ATC
erenumab; parenteral
4.3
6.8
17
40
F84.1
ICD-10 Finland
Atypical autism
40.3
6.8
8
*
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
40.3
6.8
8
*
C02AC02
ATC
guanfacine; oral
16.8
6.7
10
6
A29
ICPC
General symptom/complaint other
1.7
6.7
119
723
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.8
6.7
104
608
H03AA01
ATC
levothyroxine sodium; systemic
1.6
6.7
152
986
P22
ICPC
Child behaviour symptom/complaint
2.5
6.7
41
169
SPAT1153
SPAT
Removal of sutures
1.5
6.6
192
1318
R02
ICPC
Shortness of breath/dyspnoea
1.7
6.6
117
710
OAB42, ,
SPAT
1.5
6.6
193
1329
R4140
NOMESCO Finland
Psychotherapy
3.8
6.5
19
50
A06AD11
ATC
lactulose; oral
2.0
6.5
72
377
Z91.5
ICD-10 Finland
Personal history of self-harm
6.9
6.5
15
22
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.7
6.5
34
129
UKC02
NOMESCO Finland
Cystoscopy
2.1
6.5
63
315
SPAT1303
SPAT
Counselling and guidance related to growth and development
2.0
6.5
64
322
X78
ICD-10 Finland
Intentional self-harm by sharp object
3.2
6.5
25
80
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.4
6.4
22
65
F84.4
ICD-10 Finland
Overactive disorder associated with mental retardation and stereotyped movements
70.2
6.4
7
*
OAA65, ,
SPAT
0.6
6.4
164
2370
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
7.4
6.4
14
19
ZXY53
NOMESCO Finland
2-person team, doctor-social worker
7.4
6.4
14
19
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
6.4
110
662
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.7
6.4
127
795
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.8
6.4
98
571
N06AA06
ATC
trimipramine; systemic
3.8
6.4
19
51
OAB44, ,
SPAT
1.5
6.3
202
1416
A13
ICPC
Concern/fear medical treatment
3.5
6.3
21
61
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.5
6.3
21
61
N02CD03
ATC
fremanezumab; systemic
3.4
6.3
22
66
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.3
178
1215
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.3
6.3
20
587
R00.2
ICD-10 Finland
Palpitations
1.8
6.3
94
544
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.4
6.3
26
673
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
18.1
6.3
9
5
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
18.1
6.3
9
5
R63.4
ICD-10 Finland
Abnormal weight loss
2.7
6.3
33
126
2990A
ICD-9 Finland
Psychoses with origin specific to childhood, Infantile autism[AUTISMUS INFANTILIS,TÄYDELLINEN OIREYHTYMÄ]
+∞
6.3
6
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
6.2
174
1184
IEY17, ,
SPAT
26.8
6.2
8
*
L01
ICPC
Neck symptom/complaint
1.5
6.2
187
1293
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
7.1
6.2
14
20
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
4.0
6.2
17
43
OAA64, ,
SPAT
0.5
6.2
58
1094
R55
ICD-10 Finland
Syncope and collapse
1.9
6.2
80
443
R2130, ,
SPAT
2.0
6.1
62
315
RT150, ,
NOMESCO Finland
3.8
6.1
18
48
T83
ICPC
Overweight
2.6
6.1
33
128
F30.9
ICD-10 Finland
Manic episode, unspecified
8.6
6.1
12
14
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.7
6.0
119
744
N05AL05
ATC
amisulpride; oral
10.1
6.0
11
11
F34.8
ICD-10 Finland
Other persistent mood [affective] disorders
10.1
6.0
11
11
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.9
6.0
79
439
IEP02
NOMESCO Finland
Child-centred family therapy
3.4
6.0
21
63
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
453
1956
3.15
74.58
2.1
1.8
1.46
1.38
%
2.84
414
1788
236
760
3.64
61.42
1.7
1.5
1164.73
1120.88
nmol/l
0.31
185
593
303
1179
3.12
57.73
1.6
1.5
412.92
38758653.92
pmol/l
1.54
258
1063
384
1727
2.82
55.99
1.7
1.4
17.90
18.73
nmol/l
0.59
345
1571
564
3095
2.59
54.84
4.8
7.8
1.22
1.22
mmol/l
1.20
517
2922
600
3505
2.47
49.49
5.7
7.8
1.22
1.22
mmol/l
0.79
514
3112
1003
7576
3.32
47.09
5.4
4.0
14.56
14.46
pmol/l
0.69
928
7001
511
2835
2.43
46.48
2.0
1.7
98.86
97.30
pmol/l
0.31
315
1605
840
6042
2.40
38.90
6.5
6.9
83.49
79.21
u/l
1.31
778
5761
425
2325
2.30
38.25
2.4
2.8
2.35
2.36
mmol/l
0.63
390
2179
615
3948
2.18
36.85
3.0
2.7
66.88
68.46
nmol/l
0.79
582
3771
1076
8853
3.79
36.21
12.4
10.2
139.80
139.54
mmol/l
4.26
1046
8630
1062
8682
3.50
35.84
6.7
4.7
1.84
1.76
mu/l
1.89
1020
8308
1075
8872
3.71
35.30
12.4
10.3
3.86
3.90
mmol/l
7.00
1041
8613
990
7821
2.76
35.05
4.6
3.0
5.51
5.52
mmol/l
0.16
924
7389
62
115
5.64
32.22
11.1
12.0
0.58
0.57
mmol/l
0.08
53
110
78
180
4.57
31.53
6.5
6.2
403.39
368.43
umol/l
1.16
67
164
390
2277
2.07
28.04
2.3
2.4
2.60
2.45
mg/l
1.08
331
2010
166
681
2.68
27.16
3.2
2.6
30.74
30.70
%
0.02
126
527
216
1008
2.40
26.92
2.0
2.2
362.01
377.56
nmol/l
0.53
206
946
487
3175
1.92
24.81
3.4
3.5
28.96
30.52
u/l
0.48
463
3038
410
2536
1.95
24.36
3.0
3.8
8.44
9.27
mmol/l
1.83
340
2322
461
2982
1.90
23.81
4.7
5.7
38.87
38.25
g/l
1.87
417
2817
386
2365
1.94
23.40
2.7
2.7
54.80
55.37
u/l
0.14
342
2230
143
588
2.63
23.15
3.7
4.4
—
—
—
0
0
806
9449
0.52
21.31
3.3
3.9
—
—
—
0
0
155
697
2.41
20.69
1.6
1.7
0.15
0.23
mg/l
2.28
53
324
33
53
6.38
19.81
1.7
2.3
16.93
13.32
umol/l
0.75
33
53
872
7117
1.89
19.46
4.3
3.3
33.61
32.31
u/l
0.34
830
6895
535
3804
1.75
19.01
4.5
5.9
10.27
11.86
umol/l
2.18
479
3592
305
1832
1.90
18.99
2.5
2.2
320.62
283.13
u/l
0.14
295
1769
51
1583
0.29
18.41
1.5
1.6
1166.62
973.06
mu/l
0.44
45
1389
32
56
5.85
17.65
4.2
5.3
233.13
173.73
umol/l
0.31
16
30
796
6414
1.76
17.36
4.3
3.8
7.51
7.11
mm/h
0.56
732
6051
1101
9934
2.94
17.19
13.6
10.8
69.40
70.32
umol/l
1.02
1087
9803
1096
9962
2.67
15.04
10.8
8.8
29.88
27.89
u/l
1.95
1068
9740
71
253
2.92
15.03
1.7
1.6
456.49
367.39
mu/l
0.87
58
208
472
3416
1.64
14.52
1.6
1.5
1.42
2.01
u/ml
0.43
121
884
172
926
2.01
14.45
2.0
1.7
369.40
305.43
mu/l
1.33
142
835
604
4652
1.62
14.38
4.5
5.2
6.07
6.20
mmol/l
0.63
557
4226
102
453
2.37
13.89
2.7
3.6
1.22
1.23
mmol/l
0.43
83
396
135
688
2.09
13.13
3.6
6.8
5.19
5.06
kpa
1.14
127
662
72
1625
0.41
12.91
1.5
1.6
3.38
3.55
ratio
0.47
45
1148
28
993
0.26
12.54
1.4
1.4
—
—
—
0
0
680
5501
1.57
12.31
3.5
3.3
65.46
71.89
ug/l
0.80
624
5267
129
662
2.07
12.30
2.8
3.6
5.00
4.82
pmol/l
1.19
113
606
123
638
2.04
11.38
3.5
6.9
0.97
0.89
mmol/l
0.10
79
443
18
787
0.22
11.36
1.6
1.5
1.65
1.19
ratio
0.84
12
484
18
787
0.22
11.36
1.6
1.5
0.77
0.94
ratio
2.12
12
480
18
786
0.22
11.34
1.6
1.5
1.23
1.14
ratio
0.18
12
479
426
3172
1.54
10.76
1.9
1.8
1.53
1.37
mmol/l
1.12
356
2904
861
7457
1.59
10.71
4.5
3.7
35.55
36.14
mmol/mol
1.18
790
7203
19
773
0.23
10.68
1.5
1.5
—
—
—
0
0
677
5584
1.51
10.37
11.0
9.7
3.70
3.90
e9/l
2.23
602
4830
179
1084
1.77
10.28
4.9
9.0
1.13
1.16
mmol/l
0.62
169
1018
58
1287
0.42
9.79
1.5
1.5
3.41
3.38
mmol/l
0.05
35
824
194
1227
1.70
9.51
2.1
2.6
15.21
15.26
umol/l
0.03
178
1153
181
1129
1.71
9.33
2.1
2.6
2.61
2.50
g/l
1.95
162
1048
165
1006
1.75
9.22
2.0
2.8
24.83
24.40
%
0.12
150
944
299
2119
1.55
9.19
2.9
2.4
12.91
32.99
ng/l
1.24
135
841
96
496
2.02
8.98
1.6
1.8
3.32
3.96
mg/l
0.51
80
334
128
732
1.84
8.86
3.0
3.3
0.24
0.23
g/l
0.87
116
688
41
146
2.87
8.76
1.5
1.5
6.82
6.43
umol/l
0.22
35
133
167
1036
1.71
8.76
1.9
2.3
2.37
2.40
mmol/l
2.49
145
907
53
217
2.51
8.65
1.4
1.4
14.30
13.00
u/l
0.11
39
188
849
9341
0.66
8.29
15.7
13.1
334.86
335.07
g/l
0.28
842
9279
176
1128
1.66
8.15
2.3
2.3
10.62
13.19
nmol/l
2.82
150
1062
178
1148
1.65
8.04
4.3
6.3
0.83
0.82
mmol/l
0.93
167
1103
936
8451
1.55
7.91
4.2
3.4
4.59
4.59
mmol/l
0.02
885
8162
936
8466
1.54
7.69
4.3
3.5
2.84
2.79
mmol/l
0.99
879
8141
43
169
2.60
7.66
1.6
3.9
31.36
33.97
umol/l
0.55
36
164
875
7813
1.48
7.58
3.4
3.0
1.33
1.21
mmol/l
3.62
820
7485
914
8258
1.49
7.23
10.3
8.3
105.26
103.70
ml/min/173m2
1.68
802
7113
332
2509
1.45
7.22
3.3
3.1
0.00
0.00
estimate
1.08
142
977
66
327
2.08
6.95
1.8
1.6
0.29
0.37
nmol/l
0.89
55
272
386
3022
1.41
6.85
1.6
1.5
1.87
2.01
g/l
1.50
232
1934
925
8411
1.48
6.77
4.1
3.3
1.32
1.39
mmol/l
6.89
871
8087
11
465
0.23
6.61
1.3
1.2
—
—
—
0
0
120
754
1.66
5.98
1.7
1.7
7.92
6.90
u/l
0.49
98
584
30
698
0.41
5.66
1.7
1.8
—
—
—
0
0
81
467
1.79
5.50
4.3
6.4
56.46
70.87
ng/l
2.11
69
442
40
179
2.28
5.47
1.5
1.6
0.51
0.52
e9/l
0.03
40
179
343
4219
0.74
5.31
1.8
1.9
—
—
—
0
0
156
1073
1.52
5.31
1.9
1.9
—
—
—
0
0
222
1646
1.43
5.17
2.5
2.8
7.64
8.75
e6/l
0.39
203
1491
22
76
2.93
5.05
2.5
1.6
91.66
92.31
%
0.33
22
76
28
638
0.43
5.04
1.4
1.6
61.16
58.40
ug/l
0.15
28
638
14
28
5.05
4.95
1.0
1.0
—
—
—
0
0
298
2358
1.35
4.67
2.9
2.9
1.02
1.02
kg/l
0.07
197
1439
13
27
4.86
4.50
1.5
1.3
80.77
85.78
nmol/24h
0.07
13
27
191
1412
1.42
4.49
4.1
4.8
5.37
11.66
mg/mmol
1.84
111
1024
213
1606
1.40
4.48
1.4
1.3
15.55
22.42
iu/ml
0.82
35
388
137
956
1.49
4.36
2.9
4.3
539.32
634.32
ng/l
0.10
92
718
40
757
0.51
4.32
1.5
1.7
—
—
—
0
0
79
486
1.67
4.31
4.4
7.8
9.57
9.64
kpa
0.14
73
469
244
1918
1.34
3.93
2.5
3.1
120.62
109.42
ug/g
0.20
152
1563
146
1053
1.44
3.93
1.3
1.3
79.21
144.62
u/ml
1.42
53
385
123
864
1.47
3.80
4.1
7.6
1.57
1.26
mmol/l
0.60
106
712
37
683
0.53
3.72
2.2
2.0
—
—
—
0
0
309
2532
1.30
3.69
3.4
3.2
110.20
48.12
e6/l
0.38
253
1857
333
3949
0.78
3.55
2.9
2.8
—
—
estimate
—
0
0
1133
11039
1.93
3.54
20.4
16.1
268.82
260.61
e9/l
4.34
1106
10808
192
2443
0.74
3.46
2.5
2.5
—
—
—
0
0
1133
11044
1.92
3.45
20.3
16.0
88.20
88.55
fl
1.82
1116
10956
1133
11045
1.91
3.44
20.5
16.5
41.49
42.40
%
0.78
1116
10952
1133
11047
1.91
3.40
20.3
16.0
4.73
4.69
e12/l
1.99
1107
10807
38
673
0.55
3.35
1.5
1.5
—
—
—
0
0
189
1465
1.35
3.32
1.3
1.3
4.73
6.19
u/ml
0.21
76
572
1133
11052
1.89
3.32
20.5
16.2
139.44
138.94
g/l
0.62
1116
10963
1133
11054
1.88
3.29
20.5
16.1
6.70
6.71
e9/l
0.07
1106
10809
1022
9760
1.38
3.28
11.5
10.7
19.45
20.74
mg/l
0.65
736
7531
26
123
2.14
3.21
1.6
1.5
0.97
1.43
promille
0.84
17
94
14
49
2.88
3.19
1.0
1.5
31.93
32.78
pg
0.41
14
49
56
344
1.66
3.14
1.7
1.6
—
—
—
0
0
75
495
1.55
3.14
1.6
1.4
—
—
—
0
0
51
816
0.61
3.08
1.3
1.3
262.06
247.04
miu/ml
0.07
16
401
90
621
1.49
3.07
3.5
2.5
—
—
—
0
0
131
971
1.39
3.05
1.1
1.1
—
—
—
0
0
53
324
1.67
3.04
1.8
2.2
2.25
3.89
iu/l
2.00
27
151
106
762
1.43
2.94
2.0
1.8
—
—
—
0
0
95
669
1.46
2.94
2.3
2.2
9.35
14.87
au/ml
—
6
91
50
306
1.66
2.87
3.0
6.2
0.63
0.62
%
0.08
50
306
160
2031
0.75
2.80
2.5
2.3
—
—
—
0
0
38
217
1.78
2.79
1.6
2.8
132.25
224.65
ug/l
0.84
31
204
102
739
1.42
2.72
2.0
1.8
—
—
—
0
0
7
201
0.34
2.67
2.1
1.6
—
—
—
0
0
95
688
1.41
2.56
4.4
8.0
24.26
23.73
mmol/l
1.33
95
688
114
852
1.37
2.55
1.8
1.6
11.59
13.10
iu/l
0.32
94
678
57
373
1.56
2.53
1.4
1.5
—
—
—
0
0
107
793
1.38
2.52
4.7
9.2
104.68
104.79
mmol/l
0.13
107
793
60
398
1.54
2.51
1.5
1.7
4.45
9.49
u/ml
0.84
13
113
129
988
1.34
2.48
2.0
4.2
6.14
6.71
umol/l
0.26
106
832
15
317
0.47
2.35
1.6
1.6
—
—
—
0
0
349
3972
0.83
2.31
2.8
2.6
—
—
—
0
0
55
372
1.50
2.14
1.1
1.1
1.57
6.11
eliau/ml
—
7
59
24
130
1.86
2.13
1.8
4.4
4.97
6.39
pmol/l
1.08
24
130
43
276
1.58
2.11
2.8
3.8
69.14
100.64
ng/l
0.66
36
231
173
2099
0.79
2.11
2.3
2.3
—
—
—
0
0
34
208
1.65
2.03
1.9
1.4
315.80
344.09
ug/g
0.26
15
110
329
3727
0.84
2.02
2.7
2.5
—
—
—
0
0
9
32
2.83
2.00
1.6
1.2
8.89
10.12
u/l
—
9
26
8
27
2.98
1.94
1.1
1.3
—
—
—
0
0
16
78
2.07
1.91
1.2
1.2
99.25
119.87
pmol/l
0.97
16
78
19
99
1.93
1.91
1.4
1.4
—
—
—
0
0
42
276
1.54
1.89
1.8
2.3
—
—
—
0
0
9
35
2.58
1.80
1.6
1.2
72.67
68.25
u/l
—
9
28
113
897
1.29
1.74
1.3
1.4
142.06
337.27
u/ml
1.27
104
828
5
13
3.86
1.71
1.2
1.5
37.72
12.84
nmol/l
—
5
13
17
89
1.92
1.70
1.4
1.2
78.14
36.20
u/l
0.25
17
81
408
3688
1.16
1.69
3.1
2.8
0.00
0.01
estimate
1.31
113
881
109
866
1.29
1.67
2.4
3.2
10.25
10.29
g/l
0.05
99
807
5
14
3.58
1.61
1.6
1.5
—
—
—
0
0
10
210
0.47
1.61
1.3
1.7
7.18
7.61
mmol/l
—
10
203
13
249
0.52
1.60
1.5
1.2
—
—
—
0
0
11
50
2.21
1.57
1.0
1.6
—
—
—
0
0
11
50
2.21
1.57
1.0
1.6
—
—
—
0
0
11
50
2.21
1.57
1.0
1.6
—
—
—
0
0
254
2226
1.18
1.54
3.4
3.1
0.24
0.30
e6/l
0.20
195
1566
5
15
3.34
1.52
1.8
3.5
38.20
170.73
ng/l
—
5
15
74
568
1.32
1.48
1.9
1.8
33.46
36.68
nmol/l
0.65
74
559
17
96
1.78
1.39
1.3
1.5
—
—
—
0
0
6
23
2.62
1.37
1.0
1.1
—
—
—
0
0
15
82
1.84
1.36
1.1
1.2
—
25.00
—
0
5
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
35
241
1.47
1.33
1.6
1.9
—
—
—
0
0
20
320
0.62
1.33
1.0
1.1
—
—
—
0
0
5
18
2.79
1.28
1.4
1.4
1.15
1.19
mmol/l
—
5
18
18
108
1.68
1.22
1.2
1.4
—
—
—
0
0
15
86
1.75
1.19
1.4
1.3
—
—
—
0
0
6
26
2.31
1.19
2.0
2.3
—
—
—
0
0
8
38
2.11
1.18
1.9
1.4
207.12
187.97
u/l
—
8
38
604
5713
1.12
1.14
4.4
3.8
308.18
1194.44
e6/l
0.63
11
68
146
1254
1.19
1.14
2.6
2.6
10003.17
6934.07
u/l
0.21
35
489
14
80
1.76
1.13
1.1
1.1
—
—
—
0
0
63
495
1.29
1.12
1.6
1.8
—
—
—
0
0
30
209
1.45
1.11
2.6
2.3
10.78
9.54
mg/l
0.62
30
197
121
1027
1.20
1.08
2.6
2.6
1.11
1.06
ug/l
0.19
102
933
15
89
1.69
1.08
1.1
1.4
0.17
0.15
nmol/l
—
10
71
22
147
1.51
1.01
1.1
1.2
—
—
—
0
0
17
107
1.60
1.00
1.2
1.4
—
—
—
0
0
17
107
1.60
1.00
1.2
1.4
—
—
—
0
0
18
115
1.57
1.00
2.2
5.0
3.71
3.83
mmol/l
0.97
18
115
139
1596
0.85
0.99
2.7
2.8
312.83
325.33
umol/l
0.93
109
1500
0
29
0.00
0.98
0.0
1.4
—
20.17
—
0
6
71
866
0.81
0.97
1.6
1.4
—
—
—
0
0
0
31
0.00
0.96
0.0
1.1
—
1.31
—
0
31
0
32
0.00
0.95
0.0
1.3
—
32.00
—
0
5
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
36
269
1.35
0.93
1.6
2.0
—
—
—
0
0
16
102
1.58
0.90
1.2
1.4
—
—
—
0
0
16
103
1.56
0.87
1.2
1.4
—
—
—
0
0
16
103
1.56
0.87
1.2
1.4
—
—
—
0
0
15
95
1.59
0.87
3.4
6.1
10.88
9.39
mg/l
—
9
82
46
580
0.78
0.86
1.9
2.0
0.51
0.56
ug/l
0.25
23
206
10
57
1.76
0.83
1.0
1.0
0.46
2.49
u/ml
—
10
57
6
112
0.53
0.83
1.2
1.2
—
—
—
0
0
6
112
0.53
0.83
1.0
1.3
—
261.43
—
0
21
11
65
1.70
0.82
1.4
1.1
—
—
—
0
0
6
32
1.88
0.82
4.5
2.9
60.67
137.97
ug/l
—
6
32
15
97
1.55
0.81
1.2
1.5
5.74
4.58
u/ml
—
10
61
24
329
0.72
0.81
1.3
1.6
—
—
—
0
0
51
410
1.26
0.81
1.4
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
5
96
0.52
0.78
1.2
1.2
—
—
—
0
0
5
98
0.51
0.78
1.0
1.0
2330.20
1424.28
miu/ml
—
5
98
5
99
0.50
0.78
1.2
1.2
—
—
—
0
0
5
99
0.50
0.78
1.2
1.2
—
—
—
0
0
5
99
0.50
0.78
1.2
1.2
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
0
27
0.00
0.77
0.0
1.0
—
8.40
—
0
5
5
100
0.50
0.77
1.2
1.2
—
—
—
0
0
34
262
1.31
0.75
1.3
1.3
—
—
—
0
0
11
67
1.65
0.75
1.2
1.2
—
44.33
—
0
6
17
116
1.47
0.74
1.1
1.1
—
—
—
0
0
915
8944
1.11
0.73
16.4
13.4
13.10
13.09
%
0.21
897
8840
30
390
0.76
0.73
3.8
2.8
18.49
6.18
umol/l
0.46
20
303
13
84
1.55
0.72
1.1
1.8
—
—
—
0
0
7
41
1.71
0.70
1.7
2.0
—
—
—
0
0
131
1167
1.14
0.69
2.8
3.0
189.87
799.02
ng/l
2.13
63
576
29
375
0.77
0.69
2.2
2.0
—
—
—
0
0
18
127
1.42
0.68
1.2
1.2
97.00
94.46
%
0.19
18
120
5
28
1.79
0.66
1.0
1.9
—
—
—
0
0
5
28
1.79
0.66
1.0
1.9
—
—
—
0
0
5
28
1.79
0.66
1.0
1.9
—
—
—
0
0
8
128
0.62
0.64
1.0
1.0
—
—
—
0
0
24
182
1.33
0.61
1.2
1.4
—
—
—
0
0
25
191
1.32
0.61
1.4
1.3
2.67
5.14
u/ml
0.74
12
76
312
2934
1.09
0.61
2.8
2.5
0.00
0.01
estimate
1.34
125
852
25
192
1.31
0.59
1.3
1.4
5.17
3.84
u/ml
0.20
12
91
0
22
0.00
0.59
0.0
2.4
—
86.09
—
0
22
11
161
0.68
0.57
1.5
4.4
5.53
7.94
u/ml
0.49
11
156
8
55
1.46
0.56
1.0
1.1
218.99
201.67
iu/ml
—
8
55
6
37
1.62
0.55
1.0
1.7
—
—
—
0
0
6
37
1.62
0.55
1.0
1.7
—
—
—
0
0
6
37
1.62
0.55
1.0
1.7
—
—
—
0
0
6
37
1.62
0.55
1.0
1.7
—
—
—
0
0
8
122
0.65
0.55
1.3
1.2
—
—
—
0
0
37
303
1.23
0.55
1.8
1.9
3.36
7.84
ug/l
2.28
30
264
20
151
1.33
0.54
1.3
1.4
—
—
—
0
0
63
544
1.17
0.54
6.0
11.3
0.93
0.32
mmol/l
0.55
45
447
16
117
1.37
0.52
1.1
1.3
77.11
193.55
pmol/l
4.45
16
117
9
135
0.66
0.51
3.4
2.2
—
—
—
0
0
9
64
1.41
0.51
1.1
1.5
1.99
1.36
nmol/l
—
9
53
25
197
1.27
0.51
1.9
3.1
48.54
23.99
mu/l
0.47
19
184
25
197
1.27
0.51
1.4
1.6
—
—
—
0
0
18
236
0.76
0.51
1.0
1.1
1.77
2.35
eliau/ml
—
10
107
142
1303
1.10
0.49
3.6
2.9
4.13
3.18
e6/l
0.43
81
594
93
835
1.12
0.48
2.1
2.4
27.04
91.15
u/l
0.57
75
697
15
111
1.36
0.46
1.1
1.6
—
—
—
0
0
506
4888
1.06
0.46
3.5
3.2
0.00
2.91
estimate
0.80
144
1003
46
395
1.17
0.44
1.1
1.1
4.54
7.84
u/ml
1.01
28
205
507
4905
1.06
0.44
3.5
3.2
0.00
0.00
estimate
-0.00
138
977
18
139
1.30
0.43
1.2
1.7
—
—
—
0
0
172
1841
0.92
0.43
1.5
1.6
—
—
—
0
0
31
369
0.84
0.41
1.6
1.7
—
32.77
—
0
6
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
13
171
0.76
0.39
4.8
3.1
20.37
25.14
mg/l
—
7
116
38
442
0.86
0.39
1.2
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
998.63
—
0
19
32
270
1.19
0.38
1.1
2.4
3.38
3.52
mmol/l
0.84
32
259
25
298
0.84
0.35
1.0
1.2
—
—
—
0
0
6
43
1.40
0.35
1.5
2.1
104.67
105.67
mmol/l
—
6
43
37
426
0.86
0.35
1.8
1.6
0.01
0.20
iu/ml
—
7
70
28
237
1.19
0.34
1.8
1.7
—
—
—
0
0
24
200
1.20
0.34
1.1
1.1
—
—
—
0
0
15
119
1.26
0.32
1.7
1.5
—
—
—
0
0
67
609
1.11
0.31
1.2
1.2
2.46
2.85
u/ml
0.15
41
361
25
294
0.85
0.31
1.0
1.2
—
—
—
0
0
15
186
0.80
0.31
1.3
1.4
—
—
—
0
0
15
186
0.80
0.31
1.3
1.4
—
—
—
0
0
7
53
1.32
0.31
1.3
1.3
—
—
—
0
0
498
4855
1.04
0.30
3.5
3.1
0.00
0.00
estimate
0.50
143
1025
54
486
1.12
0.30
2.1
2.4
91.95
85.00
ml/min/173m2
0.70
21
177
197
1879
1.06
0.29
2.1
2.5
0.75
1.02
mg/l
1.25
129
1288
7
57
1.23
0.29
1.1
2.1
—
—
—
0
0
12
150
0.80
0.27
2.7
1.7
—
—
—
0
0
8
66
1.21
0.26
1.5
1.3
66.63
73.06
umol/l
—
8
66
61
558
1.10
0.26
1.1
1.1
4.07
6.84
u/ml
0.83
38
359
18
214
0.84
0.26
1.0
1.2
—
—
—
0
0
5
72
0.69
0.26
13.8
3.8
0.60
0.82
index
—
5
72
110
1035
1.07
0.25
2.2
4.3
30.02
29.79
s
0.15
105
1017
46
416
1.11
0.25
2.4
1.9
9.63
4.69
iu/ml
0.35
12
87
18
151
1.20
0.25
2.1
1.8
—
—
—
0
0
59
544
1.09
0.23
1.1
1.1
0.75
1.12
u/ml
0.42
31
288
44
483
0.91
0.22
1.5
1.6
200.67
206.11
u/ml
0.07
12
280
5
40
1.25
0.22
1.6
2.1
1.17
1.19
mmol/l
—
5
40
5
40
1.25
0.22
1.2
1.1
5.59
0.46
u/ml
—
5
40
47
430
1.10
0.21
1.1
1.1
2.76
5.24
u/ml
0.78
31
242
19
163
1.17
0.21
1.3
1.2
1.41
4.67
u/ml
0.74
11
64
0
11
0.00
0.21
0.0
3.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
51
1.18
0.19
1.5
1.3
6.50
1.50
u/ml
—
6
41
23
203
1.14
0.19
2.0
1.4
—
—
—
0
0
52
558
0.93
0.17
1.7
1.8
—
—
—
0
0
5
70
0.71
0.16
1.2
2.3
25.56
33.24
mg/l
—
5
64
5
70
0.71
0.16
2.6
1.8
—
—
—
0
0
24
215
1.12
0.16
5.0
2.9
1.38
3.40
index
1.19
13
129
73
691
1.06
0.16
2.5
5.4
212.65
241.05
u/l
1.62
68
669
48
512
0.93
0.14
1.6
1.3
—
—
—
0
0
214
2091
1.03
0.12
3.6
5.0
96.16
91.97
%
1.97
203
2055
11
127
0.86
0.12
1.3
3.0
—
—
—
0
0
32
297
1.08
0.12
1.2
2.4
343.34
436.48
mg/l
1.28
32
286
13
115
1.13
0.10
1.1
1.1
—
—
—
0
0
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
5
46
1.09
0.09
5.2
1.6
—
—
—
0
0
27
252
1.07
0.09
1.9
1.8
—
—
—
0
0
13
116
1.12
0.09
2.4
1.7
—
—
—
0
0
12
134
0.89
0.08
1.0
1.1
—
—
—
0
0
5
64
0.78
0.08
1.0
1.3
—
—
—
0
0
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
6
70
0.86
0.07
1.2
2.2
18.20
30.46
mg/l
—
6
63
7
85
0.82
0.07
3.4
1.6
—
—
—
0
0
10
89
1.12
0.07
1.8
1.5
10.52
9.42
umol/l
—
10
84
12
131
0.92
0.05
1.0
1.1
—
—
—
0
0
73
746
0.98
0.04
2.7
2.6
21.76
22.97
%
0.14
15
155
26
270
0.96
0.03
1.1
2.5
9.89
19.20
e6/l
0.52
19
191
137
1355
1.01
0.03
3.6
2.8
1.57
0.96
e6/l
0.57
79
647
11
102
1.08
0.03
1.2
1.2
—
—
—
0
0
53
541
0.98
0.03
1.2
1.1
1.25
2.38
u/ml
1.30
34
328
13
122
1.07
0.02
1.9
3.3
13.69
10.59
%
0.69
13
122
11
103
1.07
0.02
1.2
1.2
—
—
—
0
0
26
253
1.03
0.01
2.4
4.6
2.17
6.32
ug/l
1.37
18
178
12
114
1.05
0.00
2.2
3.5
—
—
—
0
0
13
124
1.05
0.00
1.5
1.6
908.50
18133.35
e6/l
—
8
88
39
386
1.01
0.00
1.1
1.1
0.28
0.89
u/ml
0.54
20
142
27
272
0.99
0.00
1.1
2.5
395.76
863.58
e6/l
0.29
21
205
22
221
1.00
0.00
1.1
1.1
260.80
163.99
iu/ml
—
5
68
30
301
1.00
0.00
8.4
13.5
17.07
16.60
%
0.49
30
287
11
107
1.03
0.00
2.5
1.9
—
—
—
0
0
12
123
0.98
0.00
1.2
1.5
—
—
—
0
0
36
355
1.01
0.00
6.5
13.5
0.64
0.66
%
0.14
36
355
15
145
1.03
0.00
2.5
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
55
0.91
-0.00
1.6
1.2
3.18
9.41
u/ml
—
5
47
0
9
0.00
-0.00
0.0
3.1
—
9.29
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
345.80
—
0
5
0
5
0.00
-0.00
0.0
4.2
—
382.40
—
0
5
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
26.93
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
8.89
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
3.03
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_AUTISM – Autism spe
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).